2015 MedTech Highlights: Low Industry Growth, VC Declines, M&A Impressive
The annual Ernst & Young Medical technology report 2015, Pulse of the Industry was released at last week’s AdvaMed 2015 conference and was met with a bit of apprehension. In an interview with MedTech Intelligence, John Babitt, partner, transaction advisory services at Ernst & Young, reviews the key concerns for the medtech industry, along with the areas of opportunity.
Areas of strength include the IPO market, with 43 companies going public in the 12-month period that ended June 30, and 16 mergers and acquisitions deals in excess of $1 billion. The gloom and doom enters in the category of overall single-digit industry growth, which saw only 2% growth, along with the decline in venture capital.
Related Articles
-
Veeva Vault CRM for Medtech is a unified customer relationship management (CRM) and content management application built for medtech sales teams, key account managers and medical affairs professionals.
-
Medtronic will invest up to $75 million and immediately begin co-promotion of CathWorks’ FFRangio System for the noninvasive diagnosis of CAD in the U.S., Europe and Japan, where it is commercially available.
-
LinkedIn has become the go-to social media platform for professionals to build their personal brands, promote their expertise and grow their careers or businesses. Following are key content characteristics and strategies shared by the leading medtech voices on LinkedIn that…
-
Share your research, experience and expertise with your peers at the upcoming Medtech Advanced Manufacturing Conference and Medtech Supply Chain Intelligence Summit. Call for abstracts is now open.
